Immuneering CorporationIMRXNASDAQ
Loading
Gross Profit Growth Under PressureDecelerating
Percentile Rank0
Studio
Year-over-Year Change

Year-over-year gross profit growth rate

Latest
-611.17%
↓ 30417% vs avg
Percentile
P0
Near historical low
Streak
1 qtr
Consecutive declineDecelerating
Average
-2.00%
Historical baseline
PeriodValue
Q4 2025-611.17%
Q3 20250.00%
Q2 20250.00%
Q1 2025100.00%
Q4 20240.00%
Q3 20240.00%
Q2 20240.00%
Q1 2024100.00%
Q4 20230.00%
Q3 2023100.00%
Q2 20230.00%
Q1 2023-100.00%
Q4 2022-97.61%
Q3 2022112.21%
Q2 2022-267.87%
Q1 2022658.34%
Q4 2021-106.32%
Q3 2021-22.96%
Q2 20210.71%
Q1 202176.72%
Q4 2020-47.81%
Q3 202050.78%
Q2 20206.91%
Q1 20200.00%